-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2023 to Q1 2025.
- Verrica Pharmaceuticals Inc. Cost of Revenue for the quarter ending March 31, 2025 was $700K, unchanged year-over-year.
- Verrica Pharmaceuticals Inc. Cost of Revenue for the twelve months ending March 31, 2025 was $2.6M.
- Verrica Pharmaceuticals Inc. annual Cost of Revenue for 2024 was $2.6M, a 420% increase from 2023.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)